{"pmid":32304276,"title":"The impact of coronavirus infectious disease 19 (COVID-19) on oral health.","text":["The impact of coronavirus infectious disease 19 (COVID-19) on oral health.","Recently emerged human-to-human transmission of COVID-19, a novel lethal strain (Chan et al., 2020) of coronavirus, caused a global pandemic burden, affecting hundreds of thousands of individuals, having life-threatening outcomes, not only in medically compromised persons but also in perfectly healthy young individuals with immunocompetent system. Apparently, this specific coronavirus must possess special abilities to spread and compromise the immune mechanisms in humans. Unfortunately, there are limited evidence-based data available, as, which is understandable clinicians and scientists must focus on life-saving aspects (Prompetchara et al., 2020). At the same time, the question arises, whether this strain possesses unique abilities to penetrate via oropharyngeal epithelial barriers and, which is even more intriguing, why infection of SARS-CoV-2 triggers such abnormal 'cytokine storm' and immunosuppression? For unknown reasons, SARS-CoV-2 does not seem to be effectively defeated by human first line protective mechanisms, neither biomolecular, nor cellular, as number of death cases in middle aged, healthy persons were reported, regardless their immune status (Mehta et al., 2020).","Oral Dis","Dziedzic, Arkadiusz","Wojtyczka, Robert","32304276"],"abstract":["Recently emerged human-to-human transmission of COVID-19, a novel lethal strain (Chan et al., 2020) of coronavirus, caused a global pandemic burden, affecting hundreds of thousands of individuals, having life-threatening outcomes, not only in medically compromised persons but also in perfectly healthy young individuals with immunocompetent system. Apparently, this specific coronavirus must possess special abilities to spread and compromise the immune mechanisms in humans. Unfortunately, there are limited evidence-based data available, as, which is understandable clinicians and scientists must focus on life-saving aspects (Prompetchara et al., 2020). At the same time, the question arises, whether this strain possesses unique abilities to penetrate via oropharyngeal epithelial barriers and, which is even more intriguing, why infection of SARS-CoV-2 triggers such abnormal 'cytokine storm' and immunosuppression? For unknown reasons, SARS-CoV-2 does not seem to be effectively defeated by human first line protective mechanisms, neither biomolecular, nor cellular, as number of death cases in middle aged, healthy persons were reported, regardless their immune status (Mehta et al., 2020)."],"journal":"Oral Dis","authors":["Dziedzic, Arkadiusz","Wojtyczka, Robert"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32304276","week":"202016|Apr 13 - Apr 19","doi":"10.1111/odi.13359","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1664431720440528898,"score":8.233237,"similar":[{"pmid":32303609,"title":"Covid-19 and immunomodulation in IBD.","text":["Covid-19 and immunomodulation in IBD.","The current coronavirus pandemic is an ongoing global health crisis due to covid-19, caused by severe acute respiratory syndrome coronavirus 2. Although covid-19 leads to little or mild flu-like symptoms in the majority of affected patients, the disease may cause severe, frequently lethal complications such as progressive pneumonia, acute respiratory distress syndrome and organ failure driven by hyperinflammation and a cytokine storm syndrome. This situation causes various major challenges for gastroenterology. In the context of IBD, several key questions arise. For instance, it is an important question to understand whether patients with IBD (eg, due to intestinal ACE2 expression) might be particularly susceptible to covid-19 and the cytokine release syndrome associated with lung injury and fatal outcomes. Another highly relevant question is how to deal with immunosuppression and immunomodulation during the current pandemic in patients with IBD and whether immunosuppression affects the progress of covid-19. Here, the current understanding of the pathophysiology of covid-19 is reviewed with special reference to immune cell activation. Moreover, the potential implications of these new insights for immunomodulation and biological therapy in IBD are discussed.","Gut","Neurath, Markus F","32303609"],"abstract":["The current coronavirus pandemic is an ongoing global health crisis due to covid-19, caused by severe acute respiratory syndrome coronavirus 2. Although covid-19 leads to little or mild flu-like symptoms in the majority of affected patients, the disease may cause severe, frequently lethal complications such as progressive pneumonia, acute respiratory distress syndrome and organ failure driven by hyperinflammation and a cytokine storm syndrome. This situation causes various major challenges for gastroenterology. In the context of IBD, several key questions arise. For instance, it is an important question to understand whether patients with IBD (eg, due to intestinal ACE2 expression) might be particularly susceptible to covid-19 and the cytokine release syndrome associated with lung injury and fatal outcomes. Another highly relevant question is how to deal with immunosuppression and immunomodulation during the current pandemic in patients with IBD and whether immunosuppression affects the progress of covid-19. Here, the current understanding of the pathophysiology of covid-19 is reviewed with special reference to immune cell activation. Moreover, the potential implications of these new insights for immunomodulation and biological therapy in IBD are discussed."],"journal":"Gut","authors":["Neurath, Markus F"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303609","week":"202016|Apr 13 - Apr 19","doi":"10.1136/gutjnl-2020-321269","keywords":["cytokines","inflammation","inflammatory bowel disease"],"source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"_version_":1664431720454160385,"score":238.0291},{"pmid":32094589,"title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.","text":["Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.","Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions. Unfortunately, there are few tools available to functionally test these viruses for their ability to infect humans, which has severely hampered efforts to predict the next zoonotic viral outbreak. Here, we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent SARS-CoV-2, for receptor usage and their ability to infect cell types from different species. We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor. We also demonstrate how different lineage B viruses can recombine to gain entry into human cells, and confirm that human ACE2 is the receptor for the recently emerging SARS-CoV-2.","Nat Microbiol","Letko, Michael","Marzi, Andrea","Munster, Vincent","32094589"],"abstract":["Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions. Unfortunately, there are few tools available to functionally test these viruses for their ability to infect humans, which has severely hampered efforts to predict the next zoonotic viral outbreak. Here, we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent SARS-CoV-2, for receptor usage and their ability to infect cell types from different species. We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor. We also demonstrate how different lineage B viruses can recombine to gain entry into human cells, and confirm that human ACE2 is the receptor for the recently emerging SARS-CoV-2."],"journal":"Nat Microbiol","authors":["Letko, Michael","Marzi, Andrea","Munster, Vincent"],"date":"2020-02-26T11:00:00Z","year":2020,"_id":"32094589","week":"20209|Feb 24 - Mar 01","doi":"10.1038/s41564-020-0688-y","source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1663352134497730561,"score":236.44237},{"pmid":32143990,"title":"The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.","text":["The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.","The 2019-nCoV is officially called SARS-CoV-2 and the disease is named COVID-19. This viral epidemic in China has led to the deaths of over 1800 people, mostly elderly or those with an underlying chronic disease or immunosuppressed state. This is the third serious Coronavirus outbreak in less than 20 years, following SARS in 2002-2003 and MERS in 2012. While human strains of Coronavirus are associated with about 15% of cases of the common cold, the SARS-CoV-2 may present with varying degrees of severity, from flu-like symptoms to death. It is currently believed that this deadly Coronavirus strain originated from wild animals at the Huanan market in Wuhan, a city in Hubei province. Bats, snakes and pangolins have been cited as potential carriers based on the sequence homology of CoV isolated from these animals and the viral nucleic acids of the virus isolated from SARS-CoV-2 infected patients. Extreme quarantine measures, including sealing off large cities, closing borders and confining people to their homes, were instituted in January 2020 to prevent spread of the virus, but by that time much of the damage had been done, as human-human transmission became evident. While these quarantine measures are necessary and have prevented a historical disaster along the lines of the Spanish flu, earlier recognition and earlier implementation of quarantine measures may have been even more effective. Lessons learned from SARS resulted in faster determination of the nucleic acid sequence and a more robust quarantine strategy. However, it is clear that finding an effective antiviral and developing a vaccine are still significant challenges. The costs of the epidemic are not limited to medical aspects, as the virus has led to significant sociological, psychological and economic effects globally. Unfortunately, emergence of SARS-CoV-2 has led to numerous reports of Asians being subjected to racist behavior and hate crimes across the world.","J Autoimmun","Yang, Yongshi","Peng, Fujun","Wang, Runsheng","Guan, Kai","Jiang, Taijiao","Xu, Guogang","Sun, Jinlyu","Chang, Christopher","32143990"],"abstract":["The 2019-nCoV is officially called SARS-CoV-2 and the disease is named COVID-19. This viral epidemic in China has led to the deaths of over 1800 people, mostly elderly or those with an underlying chronic disease or immunosuppressed state. This is the third serious Coronavirus outbreak in less than 20 years, following SARS in 2002-2003 and MERS in 2012. While human strains of Coronavirus are associated with about 15% of cases of the common cold, the SARS-CoV-2 may present with varying degrees of severity, from flu-like symptoms to death. It is currently believed that this deadly Coronavirus strain originated from wild animals at the Huanan market in Wuhan, a city in Hubei province. Bats, snakes and pangolins have been cited as potential carriers based on the sequence homology of CoV isolated from these animals and the viral nucleic acids of the virus isolated from SARS-CoV-2 infected patients. Extreme quarantine measures, including sealing off large cities, closing borders and confining people to their homes, were instituted in January 2020 to prevent spread of the virus, but by that time much of the damage had been done, as human-human transmission became evident. While these quarantine measures are necessary and have prevented a historical disaster along the lines of the Spanish flu, earlier recognition and earlier implementation of quarantine measures may have been even more effective. Lessons learned from SARS resulted in faster determination of the nucleic acid sequence and a more robust quarantine strategy. However, it is clear that finding an effective antiviral and developing a vaccine are still significant challenges. The costs of the epidemic are not limited to medical aspects, as the virus has led to significant sociological, psychological and economic effects globally. Unfortunately, emergence of SARS-CoV-2 has led to numerous reports of Asians being subjected to racist behavior and hate crimes across the world."],"journal":"J Autoimmun","authors":["Yang, Yongshi","Peng, Fujun","Wang, Runsheng","Guan, Kai","Jiang, Taijiao","Xu, Guogang","Sun, Jinlyu","Chang, Christopher"],"date":"2020-03-08T11:00:00Z","year":2020,"_id":"32143990","week":"202010|Mar 02 - Mar 08","doi":"10.1016/j.jaut.2020.102434","keywords":["Bats","Coronavirus","Epidemic","Epidemiology","Flu","Human to human transmission","Pandemic","Pneumonia","Pyroptosis","SARS-CoV","SARS-CoV-2"],"source":"PubMed","locations":["Spanish","Wuhan","China","Hubei","Asians","Huanan"],"countries":["Spain","China"],"countries_codes":["ESP|Spain","CHN|China"],"topics":["Diagnosis","Transmission","Prevention","Mechanism"],"weight":1,"_version_":1663352134174769153,"score":225.69807},{"pmid":32299202,"title":"COVID-19, immune system response, hyperinflammation and repurposing anti-rheumatic drugs.","text":["COVID-19, immune system response, hyperinflammation and repurposing anti-rheumatic drugs.","In the Wuhan province of China, in December 2019, the novel Coronavirus 2019 (COVID-19) has caused a severe involvement of the lower respiratory tract leading to an acute respiratory syndrome. Subsequently, coronavirus 2 (SARS-CoV-2) provoked a pandemic which is considered a life-threatening disease. The SARS-CoV-2, a family member of betacoronaviruses, possesses single single-stranded positive-sense RNA with typical structural proteins, involving the envelope, membrane, nucleocapsid and spike proteins that are responsible for the viral infectivity, and nonstructural proteins. The effectual host immune response including innate and adaptive immunity against SARS-Cov-2 seems crucial to control and resolve the viral infection. However, the severity and outcome of the COVID-19 might be associated with the excessive production of proinflammatory cytokines ?cytokine storm? leading to an acute respiratory distress syndrome. Regretfully, the exact pathophysiology and treatment, especially for the severe disease of COVID-19, is still uncertain. The results of preliminary studies have shown that immune-modulatory or immune-suppressive treatments such as hydroxychloroquine, interleukin (IL)-6 and IL-1 antagonists, commonly used in rheumatology, might be considered as treatment choices for COVID-19, particularly in severe lung disease. In this review, to better gain information about appropriate anti-inflammatory treatments, mostly used in rheumatology for COVID-19, we have focused the attention on the structural features of SARS-CoV-2, the host immune response against SARS-CoV-2 and its association with the cytokine storm.","Turk J Med Sci","Tufan, Abdurrahman","Avanoglu Guler, Aslihan","Matucci-Cerinic, Marco","32299202"],"abstract":["In the Wuhan province of China, in December 2019, the novel Coronavirus 2019 (COVID-19) has caused a severe involvement of the lower respiratory tract leading to an acute respiratory syndrome. Subsequently, coronavirus 2 (SARS-CoV-2) provoked a pandemic which is considered a life-threatening disease. The SARS-CoV-2, a family member of betacoronaviruses, possesses single single-stranded positive-sense RNA with typical structural proteins, involving the envelope, membrane, nucleocapsid and spike proteins that are responsible for the viral infectivity, and nonstructural proteins. The effectual host immune response including innate and adaptive immunity against SARS-Cov-2 seems crucial to control and resolve the viral infection. However, the severity and outcome of the COVID-19 might be associated with the excessive production of proinflammatory cytokines ?cytokine storm? leading to an acute respiratory distress syndrome. Regretfully, the exact pathophysiology and treatment, especially for the severe disease of COVID-19, is still uncertain. The results of preliminary studies have shown that immune-modulatory or immune-suppressive treatments such as hydroxychloroquine, interleukin (IL)-6 and IL-1 antagonists, commonly used in rheumatology, might be considered as treatment choices for COVID-19, particularly in severe lung disease. In this review, to better gain information about appropriate anti-inflammatory treatments, mostly used in rheumatology for COVID-19, we have focused the attention on the structural features of SARS-CoV-2, the host immune response against SARS-CoV-2 and its association with the cytokine storm."],"journal":"Turk J Med Sci","authors":["Tufan, Abdurrahman","Avanoglu Guler, Aslihan","Matucci-Cerinic, Marco"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32299202","week":"202016|Apr 13 - Apr 19","doi":"10.3906/sag-2004-168","keywords":["covid-19","anti-inflammatory","cytokine storm","inflammation","rheumatology","treatment"],"source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Hydroxychloroquine"],"_version_":1664357978499710977,"score":214.46413},{"pmid":32273490,"title":"Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?","text":["Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?","Pediatric coronavirus disease - 19 (COVID-19) infection is relatively mild when compared to adults, and children are reported to have a better prognosis. Mortality in children appears rare. Clinical features of COVID-19 in children include fever and cough, but a large proportion of infected children appears to be asymptomatic and may contribute to transmission. It remains unclear why children and young adults are less severely affected than older individuals, but this might involve differences in immune system function in the elderly and/or differences in the expression/function of the cellular receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) - Angiotensin converting enzyme 2 (ACE2). Laboratory findings and chest imaging may not be specific in children with COVID-19. Diagnosis is by Reverse transcriptase-Polymerase chain reaction (RT-PCR) testing of upper or lower respiratory tract secretions. This review additionally considers COVID-19 in immunosuppressed children, and also suggests a management algorithm for the few children who appear to present with life threatening infection, including the potential use of antiviral and immunomodulatory treatment. The most significant threat to global child health from SARS-CoV-2 is unlikely to be related to COVID 19 in children, but rather the socio-economic consequences of a prolonged pandemic.","Indian Pediatr","Balasubramanian, S","Rao, Neha Mohan","Goenka, Anu","Roderick, Marion","Ramanan, Athimalaipet V","32273490"],"abstract":["Pediatric coronavirus disease - 19 (COVID-19) infection is relatively mild when compared to adults, and children are reported to have a better prognosis. Mortality in children appears rare. Clinical features of COVID-19 in children include fever and cough, but a large proportion of infected children appears to be asymptomatic and may contribute to transmission. It remains unclear why children and young adults are less severely affected than older individuals, but this might involve differences in immune system function in the elderly and/or differences in the expression/function of the cellular receptor for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) - Angiotensin converting enzyme 2 (ACE2). Laboratory findings and chest imaging may not be specific in children with COVID-19. Diagnosis is by Reverse transcriptase-Polymerase chain reaction (RT-PCR) testing of upper or lower respiratory tract secretions. This review additionally considers COVID-19 in immunosuppressed children, and also suggests a management algorithm for the few children who appear to present with life threatening infection, including the potential use of antiviral and immunomodulatory treatment. The most significant threat to global child health from SARS-CoV-2 is unlikely to be related to COVID 19 in children, but rather the socio-economic consequences of a prolonged pandemic."],"journal":"Indian Pediatr","authors":["Balasubramanian, S","Rao, Neha Mohan","Goenka, Anu","Roderick, Marion","Ramanan, Athimalaipet V"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32273490","week":"202015|Apr 06 - Apr 12","source":"PubMed","topics":["Treatment","Diagnosis","Mechanism","Transmission"],"weight":1,"_version_":1663712077842219008,"score":212.00432}]}